$PATH

UiPath Q2 Profit Climbs, Raises FY27 Guidance; Pre-Market Shares Down

UiPath (PATH) reported Q2 2027 net income of $36.09M, up from $1.58M last year. Adjusted income was $80.87M, and revenue rose to $410.26M. The company raised FY27 guidance, but shares fell 8.91% pre-market to $16.62.

Original reporting
Published Sep 4, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 11:28 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UiPath Q2 Profit Climbs, Raises FY27 Guidance; Pre-Market Shares Down — source image
Decision brief

The 30-second read

$PATHBearishHigh
01

Why it matters

The earnings release provides fresh profit and revenue numbers, along with an upward revision of full‑year guidance, which directly influences investor sentiment and short‑term price action.

02

Market read

First‑report earnings with guidance raise; immediate market reaction is a notable price decline, making the news highly actionable for traders.

03

What to watch

Potential upside from upcoming enterprise contracts and AI integration not fully reflected in the market reaction.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

UiPath is a leading provider of robotic process automation software, recently expanding its AI capabilities.

Company-level read

Ticker impact

$PATHBearishHigh confidence
Context

UiPath reported Q2 2027 earnings, raised FY27 revenue and operating income guidance, and pre‑market shares fell 8.9% after the release.

Expected impact

Potential further intraday decline toward $15‑$16 range; longer‑term upside if guidance is sustained.

Evidence & confidence

Guidance increase is modest relative to prior expectations and the stock opened sharply lower, indicating traders may sell on the surprise.

Market effects

RPA sector may see heightened scrutiny of growth forecasts as investors reassess valuation multiples.

U.S. tech stocks could experience modest pressure in early trading.

Limited; impact confined to automation and enterprise software investors.

Counterpoint

Guidance raise suggests underlying momentum; the sell‑off may be overdone, presenting a buying opportunity on dip.

Key entities

  • UiPath, Inc.

    Robotic process automation software provider.

Related articles

$PATHHighAI 8/10

Why is UiPath stock sliding today?

UiPath (PATH) stock fell 9.8% in pre-market trading after Q2 FY2027 results missed growth expectations. Revenue beat estimates at $410.3M, up 13% YoY, and guidance was raised. However, annualized recurring revenue grew just 12% YoY, and net new ARR declined sequentially. Management's comments on AI strategy and leadership changes added to investor uncertainty. The stock had surged 40% before earnings, leaving it vulnerable to a sell-off.

$LULUHighAI 8/10

LULU, TSLA, ZS, PATH, SPCX: 5 Trending Stocks Today - Tesla (NASDAQ:TSLA)

Lululemon (LULU) fell 18.17% in after-hours trading after missing Q2 revenue estimates and lowering full-year guidance. Tesla (TSLA) rose 5.42% on Cybercab event anticipation. Zscaler (ZS) gained 2.94% after beating Q4 estimates and raising fiscal 2027 guidance. UiPath (PATH) edged up 1.28% but dropped 7.74% in after-hours trading. SpaceX (SPCX) jumped 6.42% on AI advancements.

$LULUHighAI 8/10

Stocks making the biggest moves after hours: Lululemon, Zscaler, Guidewire Software & more

Lululemon (LULU) fell 18% after weak Q3 guidance. Docusign (DOCU) rose 4% on earnings beat. Zscaler (ZS) gained 2% with strong Q4 results. Adobe (ADBE) dropped 1% on CEO transition. Planet Labs (PL) advanced 7% on Q2 earnings. Asana (ASAN) fell 10% on Q3 guidance. Guidewire (GWRE) dropped 15% on revenue outlook. Samsara (IOT) surged 14% on raised guidance. UiPath (PATH) lost 7% on Q3 outlook.

$PATHHighAI 8/10

UiPath Q2 2027: Revenue Beats, GAAP Operating Income Swings Positive

UiPath reported Q2 2027 revenue of $410.26M, up 13.4% YoY, beating estimates. GAAP operating income turned positive at $31.6M, driven by lower stock-based compensation and R&D spending. Annual recurring revenue reached $1.94B, up 12% YoY. Management guided Q3 revenue to $440-445M and announced leadership changes. The company repurchased $268.5M of its Class A common stock in the last six months.

$PATHHighAI 8/10

UiPath’s (NYSE:PATH) Q2 CY2026 Sales Top Estimates

UiPath (NYSE: PATH) reported Q2 CY2026 revenue of $410.3M, up 13.4% YoY, beating estimates. Guidance for next quarter is $442.5M. Non-GAAP EPS was $0.15, in line with expectations. 5-year revenue growth is 18.5% annualized, but 2-year growth slowed to 11.6%. ARR is $1.94B, with 11.7% YoY growth. CAC payback period was negative.

$IOTHighAI 8/10

After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM

Samsara (IOT) rose 11% on strong Q2 results and raised guidance. UiPath (PATH) climbed 13% with solid Q2 revenue and upbeat full-year outlook. Docusign (DOCU) gained 7% after a beat-and-raise Q2 report. Asana (ASAN) fell 12% on soft near-term profitability targets. Guidewire (GWRE) dropped 19% due to weak Q1 revenue guidance. Zscaler (ZS) edged up 1% on solid fiscal Q4 results. Planet Labs (PL) jumped 5% after reporting a surprise Q2 profit. Smith & Wesson (SWBI) surged 8.6% on strong Q1 sales.